Journey Medical Corporation —— 财务报表 (NASDAQ:DERM) | MetaTrader

展开完整图表

新闻

Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

B.Riley重申Journey Medical股票买入评级，维持12美元目标价

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

FDA为Fortress Biotech的门克斯病疗法设定新PDUFA日期

米诺环素研究显示使用16周后不会扰乱微生物群

Minocycline study shows no microbiome disruption after 16-week use

堡垒生物科技公司重新提交门克斯病治疗药物新药申请

Journey MedicalQ3每股收益及营收逊于预期

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates